Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 18, 2021, Zoetis Inc. (the "Company") announced that Dr. Catherine Knupp, DVM, MS, the Company's Executive Vice President and President of Research & Development, has provided notice of her intention to retire from her position, effective December 31, 2021, and that the Company has appointed Robert J. Polzer, PhD, who currently serves as the Company's Senior Vice President of Global Therapeutics, to succeed Dr. Knupp as the Company's Executive Vice President and President of Research & Development, effective January 1, 2022. The Company and Dr. Knupp expect Dr. Knupp to remain with the Company as an advisor assisting with the transition of her duties from January 1, 2022 until February 28, 2022.




Item 8.01. Other Events.

On October 18, 2021, the Company issued a press release announcing the appointment of Dr. Polzer and the retirement of Dr. Knupp. A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following Exhibits are filed herewith as part of this report:





Exhibit No.       Description
99.1                Press Release dated as of October 18, 2021.
104               Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)




                                      -2-

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses